Immediate Impact

60 standout
Sub-graph 1 of 22

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
1 intermediate paper

Works of Yen-Chao Wang being referenced

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation
2011

Author Peers

Author Last Decade Papers Cites
Yen-Chao Wang 318 46 138 165 3 417
Anna Laura Aloisi 305 16 92 174 6 459
Bianca Sijmons 268 17 121 236 8 507
Marcia R. Campbell 339 33 207 249 10 504
Heike Zieher 115 61 94 267 6 492
Martin Bezler 273 12 91 161 4 392
Z Zhu 135 35 84 333 8 425
Fumin Shi 244 36 155 313 5 479
Manfred Birchler 129 17 197 178 7 384
Sabarinath Vallath 204 12 39 175 6 407
Steven King 114 17 79 285 7 457

All Works

Loading papers...

Rankless by CCL
2026